Marcel Borgers

Corporate Officer/Principal presso Université Libre de Bruxelles

84 anni

Consumer Services

Health Technology

Profilo

Marcel Borgers, Ph.D.
has been Chief Scientific Officer and Chairman of our Scientific Advisory Board since May 2002.
Prior to joining, from September 1969 to April 2000, Dr. Borgers was the Vice President of Life Sciences for the Janssen Research Foundation.
Dr. Borgers held the Dr. Paul Janssen Chair in Cell Biology at the University of Antwerp from 1992 to 2002.
Dr. Borgers also has served as a professor at the Faculty of Medicine and Pharmaceutical Sciences of the Free University of Brussels since 1994 and as a Professor of Cell Biology, Faculty of Medicine, University of Maastricht, the Netherlands since 1991.
He received his doctorate in sciences from the University of Paris, Faculty of Sciences.

Posizioni attive di Marcel Borgers

Società	Posizione	Inizio
Université Libre de Bruxelles	Corporate Officer/Principal	01/01/1994
Maastricht University	Corporate Officer/Principal	01/01/1991

Tutte le posizioni attive di Marcel Borgers

Precedenti posizioni note di Marcel Borgers

Società	Posizione	Fine
University of Antwerp	Corporate Officer/Principal	01/01/2002
The Janssen Research Foundation	Corporate Officer/Principal	01/04/2000
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Marcel Borgers

Formazione di Marcel Borgers

Université Paris 1 Panthéon-Sorbonne

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Marcel Borgers

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Health Technology
The Janssen Research Foundation